Clinical Trials
All Clinical Trials - Page 48 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT04525157Phase 2Completed
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)
Afamelanotide
- NCT02172313Phase 1Completed
Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
Semaglutide
- NCT02784457Phase 2Completed
Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome
Gonadorelin
- NCT02135445Phase 2Completed
Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer
Gonadorelin
- NCT02082496Phase 2Completed
GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
Liraglutide
- NCT02089256Phase 4Completed
Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
Liraglutide
- NCT02442791N/ACompleted
GLP-1 Analogs for Neuroprotection After Cardiac Arrest
Exenatide
- NCT02170324Phase 4Completed
GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men
Exenatide
- NCT01971242Phase 2Completed
Trial of Exenatide for Parkinson's Disease
Exenatide
- NCT02162550Phase 4Unknown
Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
Exenatide
- NCT02160990Phase 4Completed
Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
Exenatide
- NCT02091492Phase 3Withdrawn
Teriparatide for Fracture Repair in Humans
Teriparatide
- NCT02294006Phase 2Unknown
Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs
Octreotide
- NCT02060383Phase 4Completed
Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Liraglutide
- NCT02146079Phase 1Completed
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects
Semaglutide
- NCT02147431Phase 1Completed
A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes
Semaglutide
- NCT02132390Phase 3Unknown
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Gonadorelin
- NCT02109315Phase 1Withdrawn
Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.
Liraglutide
- NCT02098395Phase 3Completed
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
Liraglutide
- NCT02150707N/ACompleted
The Differential Effects of Diabetes Therapy on Inflammation
Liraglutide
- NCT03068065Phase 4Completed
Antidiabetic Effects on Intrahepatic Fat
Liraglutide
- NCT02344186Phase 4Unknown
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes
Liraglutide
- NCT02138045N/ACompleted
Treatment of Diabetic Neuropathy With Liraglutide
Liraglutide
- NCT02152371Phase 3Completed
A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes
Dulaglutide
- NCT02156960Phase 4Unknown
Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients
Teriparatide
- NCT02474914N/ACompleted
Octreotide in the Prevention of Postoperative Complications After Pancreaticoduodenectomy
Octreotide
- NCT02075606Phase 4Completed
Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients
Lanreotide
- NCT01952782Phase 1Completed
Neuropeptides in Human Reproduction
Kisspeptin
- NCT02081924N/ARecruiting
Reproductive Hormones During Sustained Administration of Kisspeptin
Kisspeptin
- NCT01976728Phase 3Completed
LutrePulse Hypogonadotropic Hypogonadism
Gonadorelin
- NCT02069808Phase 4Completed
Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation
Gonadorelin
- NCT02114645N/AUnknown
The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes
Gonadorelin
- NCT02595255N/ARecruiting
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
Gonadorelin
- NCT02102646Phase 4Completed
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism
Gonadorelin
- NCT02100475Phase 3Completed
A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification
Liraglutide
- NCT02616003Phase 4Completed
Preoperative Condition in Giant Obese Patients
Liraglutide
- NCT02119819Phase 2Completed
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Exenatide
- NCT02104739Phase 4Completed
Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Exenatide
- NCT02195895Phase 2Completed
Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide
Teriparatide
- NCT02123576N/ATerminated
Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline
Octreotide
- NCT02111044Phase 2Completed
Phase II Study With ITF2984 in Acromegalic Patients
Octreotide
- NCT02054637Phase 2Unknown
Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy
Lanreotide
- NCT02115282Phase 3Active Not Recruiting
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Gonadorelin
- NCT02083185Phase 2Completed
A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer
Gonadorelin
- NCT02079870Phase 1Completed
Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo
Semaglutide
- NCT04184947N/ACompleted
Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
Liraglutide
- NCT03039049Phase 3Completed
GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT
Gonadorelin
- NCT02053779Phase 3Completed
GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT
Gonadorelin
- NCT02187250Phase 4Completed
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
Liraglutide
- NCT02073929Phase 4Completed
LIPT - Liraglutide in Polycystic Ovary Syndrome
Liraglutide